Koers Syneos Health, Inc.
Aandelen
SYNH
US87166B1026
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Colin Shannon
CEO | Chief Executive Officer | 65 | 28-09-23 |
Michael Bonello
DFI | Director of Finance/CFO | 55 | 01-07-23 |
Michael Brooks
COO | Chief Operating Officer | 50 | 14-07-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
James Momtazee
BRD | Director/Board Member | 52 | 28-09-23 |
Colin Shannon
CEO | Chief Executive Officer | 65 | 28-09-23 |
James Dimitri
BRD | Director/Board Member | - | 28-09-23 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.82% | 8 M€ | +6,91% | ||
0.77% | 2 M€ | +12,97% | ||
0.50% | 0 M€ | 0,00% | - | |
0.36% | 0 M€ | 0,00% | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,16% | 45,97 mld. | |
+53,75% | 43,93 mld. | |
+11,20% | 42,34 mld. | |
-8,59% | 28,27 mld. | |
+16,40% | 27,18 mld. | |
-19,34% | 19,44 mld. | |
+13,95% | 13,83 mld. | |
+31,56% | 12,4 mld. | |
+10,63% | 11,45 mld. |